Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3961306
Max Phase: Preclinical
Molecular Formula: C15H14Cl2FNO5
Molecular Weight: 378.18
Molecule Type: Small molecule
Associated Items:
ID: ALA3961306
Max Phase: Preclinical
Molecular Formula: C15H14Cl2FNO5
Molecular Weight: 378.18
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@]1(C(=O)O)[C@@H]2[C@@H](C(=O)O)[C@@H]2[C@H](F)[C@H]1OCc1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C15H14Cl2FNO5/c16-6-2-1-5(3-7(6)17)4-24-12-11(18)8-9(13(20)21)10(8)15(12,19)14(22)23/h1-3,8-12H,4,19H2,(H,20,21)(H,22,23)/t8-,9-,10-,11-,12+,15+/m0/s1
Standard InChI Key: UDWSIQSDTWFRQU-ANYOLZDRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 378.18 | Molecular Weight (Monoisotopic): 377.0233 | AlogP: 1.96 | #Rotatable Bonds: 5 |
Polar Surface Area: 109.85 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.69 | CX Basic pKa: 9.16 | CX LogP: -0.52 | CX LogD: -3.64 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.72 | Np Likeness Score: 0.24 |
1. Dressman BA, Tromiczak EG, Chappell MD, Tripp AE, Quimby SJ, Vetman T, Fivush AM, Matt J, Jaramillo C, Li R, Khilevich A, Blanco MJ, Smith SC, Carpintero M, de Diego JE, Barberis M, García-Cerrada S, Soriano JF, Schkeryantz JM, Witkin JM, Wafford KA, Seidel W, Britton T, Overshiner CD, Li X, Wang XS, Heinz BA, Catlow JT, Swanson S, Bedwell D, Ornstein PL, Mitch CH.. (2016) Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depression., 26 (23): [PMID:27836401] [10.1016/j.bmcl.2016.10.067] |
Source(1):